
Trump Program Broadens Access to HIV Prevention Meds
In an effort to end the HIV epidemic, President Trump announced a program to provide free HIV-prevention medication to the uninsured.
In an effort to end the HIV epidemic, President Trump announced a program to provide free HIV-prevention medication to the uninsured.
One of the administration’s goals of putting an end to the nation’s HIV epidemic within 10 years is to expand access to pre-exposure prophylaxis (PrEP). The HHS program is for the uninsured to seek free PrEP doses. The program will use donated HIV prevention drugs from Foster City, California-based Gilead Sciences Inc., makers of the PrEP drugs Truvada and Descovy, according to the Associated Press.
Drug manufacture assistance programs have already been in place for patients who cannot afford the medication, according to Shannon Stephenson, CEO,
Related:
“The
There is still a lack of knowledge regarding PrEP and its use in the general primary care setting, according to Stephenson.
“Most primary care doctors are hesitant to write the prescription because they are unfamiliar with the guidelines,” she says. “There are also barriers for both uninsured and underinsured patients who see their provider and are either unaware of the costs related to the office visit and laboratory, or that there are programs to help with the cost of the medication.”
To qualify for the
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.



















































